References
- EismannEALushESephtonSECircadian effects in cancer-relevant psychoneuroendocrine and immune pathwaysPsychoneuroendocrinology201035796397620097011
- SmolenskyMHPeppasNAChronobiology, drug delivery, and chronotherapeuticsAdv Drug Deliv Rev2007599–1082885117884237
- MurphyPJCampbellSSPhysiology of the circadian system in animals and humansJ Clin Neurophysiol19961312168988282
- HuangXLFuCJBuRFRole of circadian clocks in the development and therapeutics of cancerJ Int Med Res20113962061206622289520
- LemmerBChronobiology, drug-delivery, and chronotherapeuticsAdv Drug Deliv Rev2007599–1082582717825947
- LéviFCircadian chronotherapy for human cancersLancet Oncol20012530731511905786
- JasserSABlaskDEBrainardGCLight during darkness and cancer: relationships in circadian photoreception and tumor biologyCancer Causes Control200617451552316596305
- FuLLeeCCThe circadian clock: pacemaker and tumour suppressorNat Rev Cancer20033535036112724733
- KleveczRRBralyPSCircadian and ultradian cytokinetic rhythms of spontaneous human cancerAnn N Y Acad Sci19916182572762006788
- SephtonSSpiegelDCircadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease?Brain Behav Immun200317532132812946654
- FilipskiELéviFCircadian disruption in experimental cancer processesIntegr Cancer Ther20098429830220042408
- ManoharanSBaskarAAManivasagamTSubramanianPCircadian rhythmicity of plasma lipid peroxidation and antioxidants in oral squamous cell carcinomaSingapore Med J200546418418815800725
- ManivasagamTSubramanianPMonosodium glutamate affects the temporal characteristics of biochemical variables in Wistar ratsPol J Pharmacol2004561798415047981
- LéviFOkyarADulongSInnominatoPFClairambaultJCircadian timing in cancer treatmentsAnnu Rev Pharmacol Toxicol20105037742120055686
- InnominatoPFLéviFABjarnasonGAChronotherapy and the molecular clock: Clinical implications in oncologyAdv Drug Deliv Rev2010629–10979100120600409
- LéviFChronotherapeutics: the relevance of timing in cancer therapyCancer Causes Control200617461162116596317
- ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
- KademaniDBellRBSchmidtBLthe American Association of Oral and Maxillofacial Surgeons Task Force on Oral CancerOral and maxillofacial surgeons treating oral cancer: a preliminary report from the American Association of Oral and Maxillofacial Surgeons Task Force on Oral CancerJ Oral Maxillofac Surg200866102151215718848117
- KademaniDBellRBBagheriSPrognostic factors in intraoral squamous cell carcinoma: the influence of histologic gradeJ Oral Maxillofac Surg200563111599160516243176
- YangKCaoYAShiCQuantum dot-based visual in vivo imaging for oral squamous cell carcinoma in miceOral Oncol2010461286486821051276
- YangKZhangFJTangHIn-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in miceInt J Nanomedicine201161739174521980236
- SatoFWuYBhawalUKPERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cellsEur J Cancer201147111747175821459569
- BjarnasonGAJordanRCWoodPACircadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phasesAm J Pathol200115851793180111337377
- ZiekerDJenneIKoenigsrainerICircadian expression of clock- and tumor suppressor genes in human oral mucosaCell Physiol Biochem201026215516620798499
- GerySKomatsuNBaldjyanLYuAKooDKoefflerHPThe circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cellsMol Cell200622337538216678109